Sec Form 4 Filing - Enslin Jeffrey D. @ Glimpse Group, Inc. - 2024-02-29

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Enslin Jeffrey D.
2. Issuer Name and Ticker or Trading Symbol
Glimpse Group, Inc. [ VRAR]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
15 WEST 38TH ST, 12TH FLOOR
3. Date of Earliest Transaction (MM/DD/YY)
02/29/2024
(Street)
NEW YORK, NY10018
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2024 03/01/2024 A 215,631 ( 2 ) A $ 0 243,631 ( 4 ) I See Footnote ( 4 )
Common Stock 03/01/2024 03/01/2024 A 25,000 ( 3 ) A $ 0 243,631 ( 4 ) I See Footnote ( 4 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Purchase) ( 1 ) 02/29/2024 02/29/2024 D 359,385 ( 1 ) ( 1 ) ( 1 ) Common Stock 359,385 ( 1 ) $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Enslin Jeffrey D.
15 WEST 38TH ST, 12TH FLOOR
NEW YORK, NY10018
X
Signatures
/s/ Jeffrey D. Enslin 03/04/2024
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Represents the forfeiture of fully vested options to purchase an aggregate of 359,385 shares of the issuer's common stock, consisting of options to purchase (i) 19,833 shares of common stock granted on June 22, 2018 with an exercise price of $3.25/share, (ii) 5,210 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (iii) 25,008 shares of common stock granted on October 15, 2018 with an exercise price of $4.00/share, (iv) 225,000 shares of common stock granted on March 8, 2019 with an exercise price of $4.00/share, (v) 30,218 shares of common stock granted on October 15, 2019 with an exercise price of $4.00/share, (vi) 22,224 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (vii) 11,892 shares of common stock granted on January 1, 2022 with an exercise price of $10.20/share, and (viii) 20,000 shares of common stock granted on February 27, 2023 with an exercise price of $5.00/share.
( 2 )Represents 215,631 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024.
( 3 )Represents 25,000 shares of the issuer's common stock granted to Mr. Enslin on March 1, 2024, as director compensation for calendar year 2024.
( 4 )The 243,631 shares shown as beneficially owned does not include 102,149 shares of common stock indirectly held by Mr. Enslin, through Perimetre Capital, LLC, an entity owned and managed by Mr. Enslin. Of the 243,631 shares of common stock shown as beneficially owned following the reported transactions, Mr. Enslin directly owns 3,000 shares. The remaining 240,631 shares are indirectly held by Mr. Ensin through Perimetre Capital, LLC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.